Biological significance of localized Type IV scirrhous gastric cancer

被引:28
|
作者
Endo, Kazuya [1 ]
Sakurai, Masato [1 ]
Kusumoto, Eiji [1 ]
Uehara, Hideo [1 ]
Yamaguchi, Shohei [1 ]
Tsutsumi, Norifumi [1 ]
Ikejiri, Koji [1 ,2 ]
机构
[1] Natl Kyushu Med Ctr, Ctr Gastroenterol, Dept Surg, Fukuoka 8108563, Japan
[2] Natl Kyushu Med Ctr, Clin Res Inst, Fukuoka 8108563, Japan
关键词
gastric cancer; scirrhous; linitis plastica; prognosis; BORRMANN TYPE-IV; LINITIS PLASTICA; CARCINOMA; THERAPY;
D O I
10.3892/ol.2011.454
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognosis of type IV scirrhous gastric cancer (SGC) is extremely poor. Linitis plastica (LP), the so-called 'leather bottle stomach', is believed to be a typical case of SGC, which is usually diagnosed as a far-advanced gastric cancer. The pathogenesis of this disease remains unclear. Although typical SGC often invades the entire stomach, atypical cases show SGC localized to one region of the stomach. The aim of the present study was to investigate localized SGC (LSGC) and its biological significance. A total of 509 patients with advanced gastric cancer who underwent gastrectomy were evaluated. These patients were divided into three groups as follows: 19 patients with type IV scirrhous lesions invading the whole stomach (defined as LP), 60 patients with type IV scirrhous lesions localized in less than two thirds of the stomach (defined as LSGC) and the remaining 430 patients with all other types of gastric cancer (OGC), and then clinicopathologically compared. Results showed that LP had deeper invasion (p=0.006), more frequent peritoneal dissemination including positive cytology (p=0.01 and p=0.018) and lower curability (p=0.03) compared with LSGC, whereas LSGC showed a higher malignant potential in a number of clinicopathological factors compared with OGC. Univariate analysis showed that survival in patients with LP was significantly poorer than in those with LSGC (p=0.002) whose survival was, in turn, inferior to those with OGC. By contrast, LSGC was not a prognostic factor in SGC according to the multivariate analysis. The findings of this study suggested that the malignant status of LSGC differs from that of LP, and that curative gastrectomy effective in improving the outcome for LSGC but not for LP, as LSGC may represent the prelinitis condition.
引用
收藏
页码:94 / 99
页数:6
相关论文
共 50 条
  • [41] Retrospective analysis of prognosis for scirrhous-type gastric cancer: one institution's experience
    Rieko Nakamura
    Yoshiro Saikawa
    Norihito Wada
    Masashi Yoshida
    Tetsuro Kubota
    Koichiro Kumai
    Masaki Kitajima
    International Journal of Clinical Oncology, 2007, 12 : 291 - 294
  • [42] EARLIER DIAGNOSIS OF GASTRIC INFILTRATING CARCINOMA (SCIRRHOUS CANCER)
    KOHLI, Y
    TAKEDA, S
    KAWAI, K
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1981, 3 (01) : 17 - 20
  • [43] Exploration of factors from scirrhous-type gastric cancer, maintaining the character of cancer-associated fibroblasts
    Sakuma, Takashi
    Yashiro, Masakazu
    Wang, Qiang
    Aoyama, Rika
    Fukui, Yasuhiro
    Maruo, Koji
    Tsujio, Gen
    Sera, Tomohiro
    Yamamoto, Yurie
    Kasashima, Hiroaki
    Maeda, Kiyoshi
    CANCER SCIENCE, 2024, 115 : 853 - 853
  • [44] Retrospective analysis of prognosis for scirrhous-type gastric cancer: one institution's experience
    Nakamura, Rieko
    Saikawa, Yoshiro
    Wada, Norihito
    Yoshida, Masashi
    Kubota, Tetsuro
    Kumai, Koichiro
    Kitajima, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2007, 12 (04) : 291 - 294
  • [45] Candidate Driver Genes of Scirrhous-type Gastric Cancer Cells by RNA-Seq
    Sera, Tomohiro
    Maruo, Koji
    Tsujio, Gen
    Yamamoto, Yurie
    Sugimoto, Atsushi
    Kushiyama, Syuhei
    Togano, Shingo
    Kuroda, Kenji
    Kasashima, Hiroaki
    Yashiro, Masakazu
    CANCER SCIENCE, 2022, 113 : 411 - 411
  • [46] Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancer
    Huang, Xiao-yan
    Liu, Jin-jian
    Liu, Xiong
    Wang, Yao-hui
    Xiang, Wei
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (02) : 547 - 559
  • [47] Gastric Metastasis from Salivary Duct Carcinoma Mimicking Scirrhous Gastric Cancer
    Kishimoto, Kenichi
    Shibagaki, Kotaro
    Araki, Asuka
    Murakami, Kotaro
    Takahashi, Yusuke
    Kotani, Satoshi
    Oka, Akihiko
    Yazaki, Tomotaka
    Fukuba, Nobuhiko
    Mishima, Yoshiyuki
    Oshima, Naoki
    Kawashima, Kousaku
    Ishimura, Norihisa
    Kadota, Kyuichi
    Ishihara, Shunji
    INTERNAL MEDICINE, 2024, 63 (03) : 373 - 378
  • [48] Tranilast and cisplatin as an experimental combination therapy for scirrhous gastric cancer
    Murahashi, K
    Yashiro, M
    Inoue, T
    Nishimura, S
    Matsuoka, T
    Sawada, T
    Sowa, M
    Chung, KY
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (06) : 1235 - 1240
  • [49] Pilot study for preoperative administration of 1-OHP to patients with advanced scirrhous type gastric cancer
    Eriguchi, M
    Fujii, Y
    Takeda, Y
    Yoshizaki, I
    Akiyama, N
    Yanagie, H
    Osada, I
    Sekiguchi, M
    Matsushita, H
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 1335 - 1338
  • [50] Lipocalin-2 expression might be a novel biomarker for patients with scirrhous-type gastric cancer
    Nishimura, Sadaaki
    Yashiro, Masakazu
    Tsujio, Gen
    Yamamoto, Yurie
    Sugimoto, Atsushi
    Kushiyama, Shuhei
    Kuroda, Kenji
    Togano, Shingo
    Ohira, Masaichi
    ANNALS OF ONCOLOGY, 2021, 32 : S330 - S330